Antioxidant Status in the Soleus Muscle of Sprague-Dawley Rats in Relation to Duodenal-Jejunal Omega Switch and Different Dietary Patterns by Skrzep-Poloczek, Bronislawa et al.
Research Article
Antioxidant Status in the Soleus Muscle of Sprague-Dawley Rats in
Relation to Duodenal-Jejunal Omega Switch and Different
Dietary Patterns
Bronisława Skrzep-Poloczek ,1 Dominika Stygar ,1 Elżbieta Chełmecka,2
Katarzyna Nabrdalik ,3 Ewa Romuk ,4 Jakub Poloczek,5 Tomasz Sawczyn ,1
Konrad W. Karcz,6 and Janusz Gumprecht3
1Department of Physiology, School of Medicine with the Division of Dentristy in Zabrze, Medical University of Silesia,
Katowice, Poland
2Department of Statistics, Department of Instrumental Analysis, School of Pharmacy with the Division of Laboratory Medicine in
Sosnowiec, Medical University of Silesia, Katowice, Poland
3Department of Internal Medicine, Diabetology and Nephrology in Zabrze, Medical University of Silesia, Katowice, Poland
4Department of Biochemistry, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia,
Katowice, Poland
5Department of Rehabilitation, 3rd Specialist Hospital in Rybnik, Rybnik, Poland
6Clinic of General, Visceral, Transplantation and Vascular Surgery, Hospital of the Ludwig Maximilian University,
Munich, Germany
Correspondence should be addressed to Dominika Stygar; dstygar@gmail.com
Received 24 February 2018; Accepted 5 June 2018; Published 8 July 2018
Academic Editor: Jolanta Czuczejko
Copyright © 2018 Bronisława Skrzep-Poloczek et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work
is properly cited.
Background. Obesity and chronic ingestion of lipid-richmeals are related to an enhanced oxidative stress (OS).Aims. To examine the
inﬂuenceofduodenal-jejunal omega switch surgery in combinationwithdiﬀerentdiets on theantioxidative status in the soleusmuscle
of rats.Methods.After 8weeks on a high-fat diet (HF) or control diet (CD), rats underwent duodenal-jejunal omega switch (DJOS) or
SHAM (control) surgery. After surgery, for the next 8 weeks, half of DJOS/SHAM animals were kept on the same diet as before, and
half had a changed diet. The total superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-S-
transferase (GST), and glutathione reductase (GR) activity as well as malondialdehyde (MDA) concentration were measured in the
soleus of rats. Results. CAT and GPx activity were signiﬁcantly lower after DJOS surgery versus SHAM, regardless of the type of
diet. The activity of CAT, SOD, GR, CuZnSOD, and GPx was altered in the CD/HF or HF/CD groups. After DJOS, the lowest
muscle concentration of MDA was observed in the CD/CD group and the highest in CD/HF. Conclusions. DJOS surgery
signiﬁcantly decreases the antioxidative system in soleus muscles of rats. CD/HF and HF/CD dietary patterns lead to an increase in
antioxidative activity, while remaining on unchanged diet (CD or HF) is associated with a reduced oxidative stress.
1. Introduction
Obesity and comorbidities related to it pose a major chal-
lenge to public health systems and aﬀected individuals world-
wide. Even though there are many treatment methods
available, the one that leads to sustained and clinically rele-
vant body weight loss is bariatric surgery [1, 2]. What is even
more important is that it is also currently the only obesity
treatment modality with a proven mortality beneﬁt [1]. Sur-
gical treatment of obesity became a metabolic surgery
because it not only leads to a reduction in body weight but
also inﬂuences diﬀerent metabolic pathways, with incretin
hormones and diabetes type 2 resolution being two of the
most studied areas up to date [3]. However, one must
Hindawi
Oxidative Medicine and Cellular Longevity
Volume 2018, Article ID 3795070, 12 pages
https://doi.org/10.1155/2018/3795070
remember that obesity as well as chronic ingestion of lipid-
rich meals are related also to an enhanced oxidative stress
which in turn causes many unfavourable health conse-
quences [4–7]. Oxidative stress (OS) is just a general term
for the cellular damage being caused by an imbalance
between prooxidants such as reactive oxygen species (ROS)
and antioxidants in favour of the ﬁrst one mentioned [8].
ROS are necessary for many physiological functions; how-
ever, to maintain a physiologically beneﬁcial level of ROS
antioxidants, which are enzymatic and nonenzymatic mole-
cules, is crucial [9]. Markers indicative of oxidative stress
include elevated measures of reactive oxygen species (ROS)
and diminished antioxidant defence, associated with lower
antioxidant enzyme levels [4, 5]. OS is also related to direct
damage to lipids, with the production of end products of lipid
peroxidation with malondialdehyde (MDA) being the most
mutagenic one [10]. One of many organs that can be aﬀected
by OS associated with obesogenic conditions like obesity
itself and high-fat diet (HFD) is the skeletal muscle. The high
abundance of fat exceeds the ability of the muscle to oxidize
this substrate, which leads to intramyocellular deposition
and intermission of normal muscle function, with lipotoxi-
city as a consequence [11]. Scientists are trying to understand
the inﬂuence of various aspects related to diﬀerent treatment
methods like diets or metabolic surgery procedures on
humans using animal models. Regarding HFD diet, bariatric
surgery, and OS, there have been only single studies related to
models of oxidative stress markers performed; however, nei-
ther one took into consideration all three mentioned aspects
in one experiment. In relation to HF diet, Auberval et al.
proved the increase of tissue but not plasma oxidative stress
among the studied animals [12] and Pinho et al. revealed that
HFD induces skeletal muscle OS in rats [13]. Similarly,
bariatric surgery procedures have been linked to a reduction
in oxidative stress in rats [14]. DJOS is a relatively new tech-
nique; thus, an animal model, for exploring the long-term
physiological eﬀects and pathophysiological outcomes of this
procedure, is still needed [15, 16]. DJOS is a type of bypass-
like procedure, with proximal loop duodenoenterostomy,
where the pylorus of the patients is saved. This type of
surgery allows for direct hindgut stimulation [17, 18]. The
biochemical mechanisms responsible for the pathophysio-
logical traits of obesity, insulin resistance, and type 2 diabetes
mellitus are incompletely understood. In the presented study,
we aimed to assess the inﬂuence of duodenal-jejunal omega
switch (DJOS) surgery in combination with diﬀerent types
of diet on antioxidant status in the soleus skeletal muscles
of rats, which to our best knowledge have not been studied
up to date, neither in humans nor in animals.
2. Materials and Methods
2.1. Animals and Diets. The study was performed in accor-
dance with the Guide for the Care and Use of Laboratory
Animals. Male Sprague-Dawley rats (Charles River Breeding
Laboratories, Wilmington, Mass) aged 7 weeks, 200± 7 g,
were housed in a 12 h light-dark cycle, 22°C, and 40–60%
humidity. All rats had free access to water and rat food (Pro-
vimi Kliba AG, Kaiseraugst, Switzerland). The control group
was maintained on ssniﬀ® EF R/M. Obesity was induced by
placing the animals on a high-fat diet (HF; 23.0 kJ/g, 59%
fat, 27% carbohydrate, and 14% protein (EF RAT/E15744/
ssniﬀ Spezialdiäten GmbH) for an average of two months.
Animals maintained on the HF diet were pair-fed (kcal) with
the animals exposed to an ad libitum control diet. The energy
content of the high-fat and standard diets were 5.04 and
3.59 kcal/g (20.1 and 15.0 kJ/g), respectively.
2.2. Experimental Design. This individual study is based on
an experimental design applied and described in an earlier
work by Stygar et al. [19]. After one week of acclimatisation,
the animals were assigned to the CD (n = 28) and HF groups
(n = 28). After 8 weeks, both groups underwent the two dif-
ferent types of surgery SHAM, which is a control type of sur-
gery (n = 14), and DJOS (n = 14), presented in Figure 1(a).
After the surgery, the two groups of animals fed previously
with CD or HF diets were divided further into 8 groups,
depending on the postoperation diet regimen. In each sur-
gery group, that is, SHAM and DJOS, 7 animals were kept
on the same diet as before the surgery, and another 7 had
the diet changed (Figure 1(a)). A number of rats were kept
as small as possible in consideration of the “3Rs” for the
humane treatment of animals [20]. All 7 rats survived in 7
out of 8 experimental groups. In HF/SHAM/CD, 6 out of 7
rats survived the experiment.
A DJOS and SHAM surgery was performed according to
Karcz et al.’s methodology [16], described in the aforemen-
tioned study [19]. To perform DJOS surgery, the animals
were anaesthetised with 2% isoﬂurane (AbbVie Deutschland
GmbH & Co. KG, Ludwigshafen, Germany) and oxygen ﬂow
at 2 l/min under spontaneous breathing. Analgesia with xyla-
zine (5mg/kg, ip; Xylapan, Vetoquinol Biovet, Poland) and
antibiotic prophylaxis with gentamicin were applied. The
gastric volume was left intact, whereas the entire duodenum
and the proximal jejunum were bypassed. The stomach was
separated from the duodenum below the pylorus. The distal
part of the transected duodenum was closed using Prolene
6/0 (Ethicon). The position of the duodenoenterostomy was
determined to be at the aboral of the Treitz ligament, located
approximately at one-third of the total small bowel length for
DJOS. The duodenojejunostomy was performed as a simple
antecolic, continuous end-to-side, hand-sewn, extramucosal
anastomosis using 6-0 sutures. Postoperative analgesia was
performed using carprofen (4mg/kg, sc; Rimadyl, Pﬁzer,
Switzerland) for 3 consecutive days after the surgery.
For the type of control operation called SHAM, transec-
tions and reanastomosis of the gastrointestinal tract were
performed at the corresponding sites where enterotomies
were performed for the duodenojejunostomy, thereby main-
taining the physiological conduit of food passage through the
bowel (Figures 1(b) and 1(c)).
2.3. Tissue Collection. After 16 weeks of the experiment and 8
weeks after the surgery, the tissue of the soleus muscle was
harvested and the animals were euthanized. 100mg of muscle
tissue was homogenized in 1ml of a homogenising buﬀer. All
samples were snap frozen in liquid nitrogen and stored at
−80°C until further analysis. All experimental procedures
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were approved by the Ethical Committee for Animal Experi-
mentation of the Medical University of Silesia (58/2014). All
applicable institutional and/or national guidelines for the care
and use of animals were followed (Directive 2010/63/EU).
2.4. Oxidative Stress Marker Analysis
2.4.1. Oxidative Enzyme Analysis. 8 weeks after DJOS and
SHAM surgery, an antioxidant system was analysed deter-
mining the activity of the following antioxidant enzymes in
soleus muscle homogenates: glutathione reductase (glutathi-
one-disulﬁde reductase, GR, and GSR), catalase (CAT),
glutathione peroxidase (GPx), glutathione-S-transferase
(GST), and total superoxide dismutase activity (SOD) and
the nonenzymatic antioxidant system—lipid peroxidation
by determining the malondialdehyde concentration.
2.4.2. Glutathione Reductase Activity (EC 1.8.1.7). GR enzy-
matic activity in the muscle homogenates was evaluated by
a decrease in the concentration of NADPH in the samples
using GR buﬀer (200mM sodium phosphate pH7.5,
6.3mm EDTA), and kinetic reading was performed at a
wavelength of 340nm for 10 minutes [21].
2.4.3. Catalase Activity (EC 1.11.1.6). The catalase activity in
muscle homogenates was measured using Aebi’s methods.
Brieﬂy, 50mM TRIS/HCl buﬀer, pH7.4, and perhydrol
were mixed with 50μl of homogenate. After 10 seconds,
the absorbance was read at λ = 240 nm, every 30 seconds
for 2 minutes. Enzymatic activity was expressed in IU/mg
protein [22].
2.4.4. Glutathione Peroxidase Activity (EC 1.11.1.9). To mea-
sure the activity of glutathione peroxidase, the muscle
homogenates were incubated with a GPx buﬀer (100mM
potassium phosphate with 1mM EDTA pH7.7), 40mM
sodium azide, GSH (diluted in 5% metaphosphoric acid),
GR (GPx diluted in the buﬀer), NADPH (diluted with
sodium bicarbonate 5%), and 0.5mM tert-butyl. The decay
of NADPH concentration was evaluated for 10 minutes in a
spectrophotometer, at 340 nm [23].
2.4.5. Glutathione-S-transferase Activity (EC 2.5.1.18). Trans-
ferase activity of glutathione-S-transferase in muscle homog-
enates was estimated by the kinetic method, previously
described by Habig and Jakoby [24]. 1-Chloro-2,3-dinitro-
benzene was used as a substrate, and results are expressed
in IU/g protein.
2.4.6. Superoxide Dismutase Analysis (EC 1.15.1.1). SOD iso-
enzyme activity was determined with the use of the spectro-
photometric method by Oyanagui [25]. KCN was used as
the inhibitor of the CuZnSOD isoenzyme. CuZnSOD activity
was calculated as the diﬀerence between total SOD activity
and MnSOD activity. SOD activity was calculated against a
blank probe (containing bidistilled water). Enzyme activity
was expressed as nitrite units (NU) per mg of protein in tis-
sue. One NU exhibits 50% inhibition of formation of nitrite
ion under the method’s condition [25].
2.4.7. Lipid Peroxidation. Malondialdehyde (MDA) concen-
tration was measured in samples of muscle homogenates
based on Ohkawa et al.’s method, using the reaction with
thiobarbituric acid, with spectrophotometric detection
employing 515nm excitation and 552 nm emission wave-
lengths. MDA concentration was calculated from the stan-
dard curve, prepared from 1,1,3,3-tetraethoxypropane [26].
2.4.8. Protein Concentration. Protein concentration was
determined by Lowry methods using bovine serum albumin
as the standard [27].
3. Statistical Analysis
Statistical analysis was performed using STATISTICA 12.5
PL (StatSoft, Cracow, Poland). Statistical signiﬁcance was
set at a p value below 0.05. All tests were two-tailed. Interval
data were expressed as mean value ± standard deviation in
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Figure 1: (a) Schematic illustration of DJOS and (b) SHAM surgery, respectively, and (c) scheme of experimental groups.
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the case of a normal distribution or as median/lower–
upper quartile range in the case of data with skewed or
nonnormal distribution. Distribution of variables was eval-
uated by the Shapiro-Wilk test and the quantile-quantile
plot; homogeneity of variances was assessed by the Levene
test. For comparison of data, the two-way parametric
ANOVA with post hoc contrast analysis or nonparametric
Kruskal-Wallis test or Mann–Whitney U test were used.
In case of skewed data distribution, logarithmic transfor-
mation was done before analysis.
4. Results
The results of body weight change after DJOS and SHAM sur-
gery in all experimental groups were previously presented by
Stygar et al. [19]. The values of antioxidative systems for DJOS-
and SHAM-operated groups are presented in Table 1. Table 2
presents results of multiple comparisons in contrast analysis of
DJOS- and SHAM-operated groups in relation to diet used
before and after surgery. Column one presents a comparison
between DJOS and SHAM surgery associated with diﬀerent
diets, column two shows comparisons between dietary groups
of DJOS-operated animals, and column three shows compari-
sons between dietary groups of SHAM-operated animals.
4.1. Oxidative Enzyme Systems
4.1.1. Glutathione Reductase. GR muscle’s activity in DJOS-
operated animals compared to SHAM-operated ones was
signiﬁcantly diﬀerent among HF/HF, HF/CD, and CD/CD
diet groups (Figure 2(a), Tables 1 and 2). In the DJOS surgery
group, GR muscle’s activity in the HF/HF group was signiﬁ-
cantly lower when compared to the SHAM-operated HF/HF
diet group. Oppositely, in the DJOS surgery group, GR mus-
cle’s activity in the HF/CD and CD/CD diet groups were sig-
niﬁcantly higher when compared to the SHAM-operated
HF/CD and CD/CD diet groups of animals. There was no
diﬀerence among the CD/HF diet group of DJOS- and
SHAM-operated animals in relation to GR muscle’s activity.
Taking into consideration DJOS surgery, there was a sig-
niﬁcant diﬀerence in terms of GR muscle’s activity in the
studied diet groups, namely, HF/HF and HF/CD, HF/HF
and CD/HF, HF/HF and CD/CD, HF/CD and CD/HF, HF/
CD and CD/CD, and CD/HF and CD/CD (Figure 2(a),
Tables 1 and 2). The lowest GR muscle’s activity was
observed among the HF/HF diet group and the highest
among the CD/CD group (Figure 2(a), Tables 1 and 2).
There were no signiﬁcant diﬀerences in terms of GR
muscle’s activity in the studied diet groups in SHAM-
operated animals.
4.1.2. Catalase. CAT muscle’s activity in DJOS-operated
animals compared to SHAM-operated ones was signiﬁcantly
diﬀerent among the HF/HF, HF/CD, CD/HF, and CD/CD
diet groups (Figure 2(b), Tables 1 and 2). In the DJOS group,
CAT activity was signiﬁcantly lower in HF/HF, HF/CD, and
CD/HF when compared to the HF/HF, HF/CD, and CD/HF
diet groups of SHAM-operated animals. Oppositely, in the
DJOS group, CAT activity was signiﬁcantly higher in the
CD/CD diet group when compared to the SHAM CD/CD
diet group (Figure 2(b); Tables 1 and 2).
For the DJOS surgery, a signiﬁcant diﬀerence in terms of
CAT activity among the studied diet groups, namely, HF/HF
and CD/HF, HF/CD and CD/HF, and CD/HF and CD/CD,
was observed. The lowest CAT muscle activity was observed
in the HF/HF diet group and the highest among the CD/HF
diet group (Figure 2(b); Tables 1 and 2).
There was a signiﬁcant diﬀerence in terms of CAT activ-
ity among the SHAM-operated studied diet groups, namely,
HF/HF and CD/HF, HF/HF and CD/CD, HF/CD and CD/
HF, and CD/HF and CD/CD (Figure 2(b); Tables 1 and 2),
with the lowest value observed among the CD/CD group
and the highest value among the CD/HF studied group
(Figure 2(b); Tables 1 and 2).
4.1.3. Glutathione Peroxidase Activity. GPx muscle’s activity
in DJOS-operated animals compared to SHAM-operated
ones was signiﬁcantly lowered among all analysed diet
groups, namely, HF/HF, HF/CD, CD/HF, and CD/CD
(Figure 2(c), Tables 1 and 2).
In DJOS-operated animals, there were signiﬁcant diﬀer-
ences in terms of GPx muscle’s activity between each of the
four diet groups, namely, HF/HF and HF/CD, HF/HF and
CD/HF, HF/HF and CD/CD, HF/CD and CD/HF, HF/CD
and CD/CD, and CD/HF and CD/CD, with the lowest value
observed in the CD/CD group and the highest value in the
CD/HF diet group (Figure 2(c), Tables 1 and 2).
In SHAM-operated animals, there were signiﬁcant diﬀer-
ences in terms of GPx muscle’s activity between three out of
four diet groups, namely, HF/HF and CD/HF, HF/HF and
CD/CD, HF/CD and CD/CD, and CD/HF and CD/CD, with
the lowest value observed among the CD/CD diet group and
the highest one among the CD/HF diet group (Figure2(c);
Tables 1 and 2).
4.1.4. Glutathione-S-transferase Activity. GST muscle’s activ-
ity in DJOS-operated animals compared to SHAM-operated
ones was signiﬁcantly lowered in HF/HF and CD/CD diet
groups (Figure 2(d), Tables 1 and 2).
After DJOS surgery, there were signiﬁcant diﬀerences in
terms of GST muscle’s activity between studied diet groups,
namely, the HF/HF and CD/HF, HF/HF and CD/CD, HF/
CD and CD/CD, and CD/HF and CD/CD diet study groups,
with the lowest value observed among the CD/CD diet group
and the highest ones among the CD/HF diet group
(Figure 2(d), Tables 1 and 2).
There were no signiﬁcant diﬀerences in terms of GST
muscle’s activity among any diet groups in SHAM-operated
rats (Figure 2(d), Tables 1 and 2).
4.1.5. Total Superoxide Dismutase Activity. SOD muscle’s
activity in DJOS-operated animals compared to SHAM-
operated ones was signiﬁcantly lowered in the HF/CD and
CD/HF study diet groups (Figure 3(a), Tables 1 and 2).
After DJOS surgery, there were signiﬁcant diﬀerences in
terms of SOD muscle’s activity between the studied diet
groups, namely, HF/HF and CD/HF, HF/HF and CD/CD,
HF/CD and CD/HF, and CD/HF and CD/CD, with the
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lowest value observed among the CD/CD diet group and the
highest ones among the CD/HF diet group (Figure 3(a),
Tables 1 and 2).
In SHAM-operated animals, there were signiﬁcant diﬀer-
ences in terms of SOD muscle’s activity between four diet
groups, namely, HF/HF and CD/CD, HF/CD and CD/CD,
CD/HF, and CD/CD, with the lowest value observed among
the CD/CD diet group (Figure 3(a), Tables 1 and 2).
4.1.6. Mn Superoxide Dismutase Activity. MnSOD muscle’s
activity in DJOS-operated animals compared to SHAM-
operated ones was signiﬁcantly lowered in the CD/CD study
diet group (Figure 3(b), Tables 1 and 2).
After DJOS, there were signiﬁcant diﬀerences in terms
of MnSOD muscle’s activity between studied groups,
namely, HF/HF and CD/HF, HF/HF and CD/HF, HF/
CD and CD/HF, and CD/HF and CD/CD studied diet
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Figure 2: (a) Mean values of GR (IU/g) activity in four groups subjected to diﬀerent dietary patterns, according to the DJOS and SHAM
operation type. Statistical signiﬁcance was set at p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS: duodenal-jejunal omega
switch surgery; HF: high-fat diet; CD: control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8 weeks before/8 weeks after surgery. (b)
Mean values of CAT (IU/g) activity in four groups subjected to diﬀerent dietary patterns, according to the DJOS and SHAM operation
type. Statistical signiﬁcance was set at p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS: duodenal-jejunal omega switch
surgery; HF: high-fat diet; CD: control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8 weeks before/8 weeks after surgery. (c) Mean
values of GPX (IU/g) activity in four groups subjected to diﬀerent dietary patterns, according to the DJOS and SHAM operation type.
Statistical signiﬁcance was set at p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS: duodenal-jejunal omega switch surgery; HF:
high-fat diet; CD: control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8 weeks before/8 weeks after surgery. (d) Mean values of
GST (IU/g) activity in four groups subjected to diﬀerent dietary patterns, according to the DJOS and SHAM operation type. Statistical
signiﬁcance was set at p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS: duodenal-jejunal omega switch surgery; HF: high-fat
diet; CD: control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8 weeks before/8 weeks after surgery.
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groups, with the lowest value observed among the HF/HF
diet group (Figure 3(b), Table 2).
In SHAM-operated animals, there were signiﬁcant diﬀer-
ences in terms of SOD muscle’s activity between the studied
groups, namely, HF/HF and HF/CD, HF/HF and CD/HF,
HF/HF and CD/CD, HF/CD and CD/HF, and CD/HF and
CD/CD, with the lowest value observed among the HF/HF
one (Figure 3(b), Tables 1 and 2).
4.1.7. CuZn Superoxide Dismutase Activity. CuZnSOD
muscle’s activity in DJOS-operated animals compared to
SHAM-operated ones was signiﬁcantly diﬀerent in all stud-
ied diet groups. Among HF/HF, CD/HF, and CD/CD diet
groups of DJOS-operated animals, ZnCuSOD activity was
signiﬁcantly lower when compared to the HF/HF, CD/HF,
and CD/CD diet groups of SHAM-operated animals
(Figure 3(c), Tables 1 and 2). In the HF/CD diet group of
DJOS-operated animals, ZnCuSOD activity was signiﬁcantly
higher when compared to the HF/CD diet group of SHAM-
operated animals (Figure 3(c), Tables 1 and 2).
After DJOS surgery, there were signiﬁcant diﬀerences in
terms of CuZnSODmuscle’s activity between the studied diet
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Figure 3: (a) Mean values of SOD (NU/mg) activity in four groups subjected to diﬀerent dietary patterns, according to the DJOS and SHAM
operation type. Statistical signiﬁcance was set at p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS: duodenal-jejunal omega switch
surgery; HF: high-fat diet; CD: control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8 weeks before/8 weeks after surgery. (b) Mean
values of MnSOD (NU/mg) activity in four groups subjected to diﬀerent dietary patterns, according to the DJOS and SHAM operation
type. Statistical signiﬁcance was set at p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS: duodenal-jejunal omega switch
surgery; HF: high-fat diet; CD: control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8 weeks before/8 weeks after surgery. (c) Mean
values of CuZnSOD (NU/mg) activity in four groups subjected to diﬀerent dietary patterns, according to the DJOS and SHAM operation
type. Statistical signiﬁcance was set at p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS: duodenal-jejunal omega switch
surgery; HF: high-fat diet; CD: control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8 weeks before/8 weeks after surgery.
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groups, namely, HF/HF and HF/CD, HF/HF and CD/HF,
HF/HF and CD/CD, HF/CD and CD/CD, and CD/HF and
CD/CD, with the lowest two values observed in the CD/CD
diet group and the highest value in the HF/HF group
(Figure 3(c), Tables 1 and 2).
After SHAM surgery, there were signiﬁcant diﬀerences in
terms of CuZnSODmuscle’s activity between the studied diet
groups, namely, HF/HF and HF/CD, HF/HF and CD/HF,
HF/HF and CD/CD, HF/CD and CD/HF, and CD/HF and
CD/CD, with the lowest value observed among the HF/CD
diet group and the highest among the HF/HF studied group
(Figure 3(c), Tables 1 and 2).
4.1.8. Lipid Peroxidation
(1) Malondialdehyde Concentration. MDA muscle’s activity
in DJOS-operated animals compared to SHAM-operated
ones was signiﬁcantly lowered in the HF/CD and CD/CD
study diet groups (Figure 4, Tables 1 and 2).
After DJOS surgery, there were signiﬁcant diﬀerences in
terms of MDA muscle’s concentrations between the studied
groups, namely, HF/HF and HF/CD, HF/HF and CD/HF,
HF/HF and CD/CD, HF/CD and CD/CD, and CD/HF and
CD/CD, with the lowest value observed in the CD/CD diet
group and the highest in the CD/HF diet group (Figure 4,
Tables 1 and 2).
After SHAM surgery, there were signiﬁcant diﬀerences in
terms of MDA muscle’s activity between the studied groups,
namely, HF/HF and HF/CD, HF/HF and CD/HF, HF/CD
and CD/HF, HF/CD and CD/CD, and CD/HF and CD/CD,
with the lowest value observed in the CD/CD diet group
and the highest value in the HF/CD diet group (Figure 4,
Tables 1 and 2).
5. Discussion
It is already known that both high-fat diet and/or obesity lead
to an increased OS [28]. It is however not known whether dif-
ferent types of diet combined with bariatric surgery decrease
the skeletal muscles’ OS. In this study, we have, for the ﬁrst
time, proven that DJOS surgery positively reduced the redox
state of the rat’s soleus muscle cells in comparison to the
SHAM procedure. It was also noticed that the type of diet
applied before and after DJOS and SHAM surgery is associ-
ated with the diﬀerent levels of OS status, antioxidant enzy-
matic activity, and nonenzymatic system in the soleus
muscle of rats. Thus, the antioxidant activity was related to
the type of diet before and after the surgery and the studied
enzyme. Treatment with the control dietary pattern or HF
diet, both before and after surgery, was associated with the
lowest antioxidants’ activity, while changing the diet from
CD to HF or the reverse signiﬁcantly increased the ROS gen-
eration and lipid peroxidation measured by MDA concentra-
tion. Because there were no studies performed up to date that
took under consideration the association of bariatric surgery
in relation to diet with skeletal muscle’s antioxidant system
activity, we will refer to studies examining single components
of our experiment in this discussion section.
Metabolic disorders are associated with alterations in
lipid and glucose metabolism in skeletal muscle. Some of
those alterations are explained by defects in insulin signal-
ling, glucose transport, or glycogen synthesis in skeletal
muscles [29, 30]. This leads to deterioration of metabolic
function and is associated with mitochondrial dysfunction
[31–33]. It is known that altered mitochondrial function in
skeletal muscle leads to reduced fatty acid oxidation and
reduction of insulin-stimulated glucose transport. This
may be understood as a hallmark of insulin resistance
and diabetes mellitus type 2 [34]. Under obesogenic condi-
tions, for example, high-fat diet, the ability of muscle tis-
sue to oxidize the fat content is highly reduced and may
lead to an increased level of ROS; thus, ROS production
is intensiﬁed under inﬂammatory conditions characteristic
for obesity. ROS, by its dual nature, may play a pathogenic
role in many muscular diseases or lead to further injury by
oxidatively damaging diﬀerentiating myoblasts and myo-
tubes [31]. Conversely, together with other factors such
as growth factors and chemokines, ROS takes part in a
process of muscle regeneration and repair [31]. ROS also
stimulates signalling pathways relevant to skeletal muscle
metabolism, homeostasis, and adaptation [35]. The muscle
cellular antioxidant capacity is the main factor, which can
curb the negative activity of ROS, and the modulation of
muscle sensitivity to ROS depends on the ROS level. The
antioxidant enzymes keep ROS on the physiological level,
where they can act as defence systems, signalling mole-
cules, and mitochondrial function modulators [35, 36].
In our study, the CAT and GPx activity was signiﬁcantly
lower after DJOS surgery in comparison with the SHAM one
in all diet study groups. It was not dependent on diet; never-
theless, the redox state of the muscle cells and activity of
CAT, SOD, and GPx was altered in the groups maintained
on the mixed CD/HF diet. GR and CuZnSOD activity was
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Figure 4: Mean values of MDA (μmol/g) concentration in four
groups subjected to diﬀerent dietary patterns, according to the
DJOS and SHAM operation type. Statistical signiﬁcance was set at
p < 0 05. Vertical lines depict 95% conﬁdence interval. DJOS:
duodenal-jejunal omega switch surgery; HF: high-fat diet; CD:
control diet; HF/HF, CD/HF, HF/CD, CD/CD: type of diet 8
weeks before/8 weeks after surgery.
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increased after DJOS surgery compared to the SHAM one
among animals fed with the HF diet before the surgery and
CD following the procedure. These enzymatic antioxidants
are the main force of prevention mechanisms, controlling
the formation of ROS [37, 38]. Apart from ATP production,
mitochondrial areas are major sites for ROS production.
Characteristic of rat soleus muscles are mitochondria-rich
slow-twitch type I ﬁbres, which exhibit oxidative metabolism
and fatigue resistance [39]. Long-term exposure to an HF diet
increases the muscle rates of fatty acid oxidation regardless of
the ﬁbre type [13]. Chronic disturbances in energy metabo-
lism caused by excessive food intake and obesity lead to an
increase in ROS production and mitochondrial dysfunction
[34]. The changes in the structure and functions of mito-
chondria in the skeletal muscles of obese mice favour the
generation of ROS, the development of oxidative stress, and
insulin resistance [40, 41]. Chronic oxidative stress and
inﬂammation mainly derived from reduced mitochondrial
mass, changed morphology, and mitochondrial metabolic
dysfunction are proven to induce lipid accumulation and
insulin resistance in muscle tissue [34, 42–44]. Recent labora-
tory ﬁndings prove that a high-fat diet changes the mito-
chondrial structure in mice and the optimal mitochondrial
function is obtained only under the condition of caloric
restriction or regular diet [34]. Our ﬁndings show that DJOS
surgery reduces the deleterious impact of an HF/HF diet on
OS but does not act eﬃciently under the condition of a
change in dietary pattern. Other studies conﬁrm the reduc-
tion in oxidative stress and a downregulation of antioxidant
enzymes after duodenojejunostomy in the insulin resistance
and diabetic animal models [14].
In this study, the HF diet, applied before and after sur-
gery, stimulated antioxidative activity less than the CD/HF
and HF/CD ones. Here, rats were exposed to an HF diet for
16 weeks, and this could have allowed enough time for the
antioxidant system to adapt to a proinﬂammatory diet and
quench ROS production. In this manner, it may be inter-
preted as an increase in the oxidative capacity of the soleus
muscle. After DJOS surgery the activity of Mn SOD, CAT,
GPx, GR, and GST was reduced in the presence of the HF/
HF diet when compared to the HF/CD and CD/HF dietary
groups. Signiﬁcant diﬀerences in the activity of all studied
enzymes were observed between the HF/HF and CD/HF
groups, with higher activity of CAT, GPx, GST, Mn SOD,
and SOD and MDA concentration after the change of the
diet from CD to HF. The activity of studied enzymes and
MDA concentration was signiﬁcantly higher also in the
CD/HF dietary pattern when compared to CD/CD, with
the exception of GR. The diﬀerent activity proﬁle of ZnCu
SOD, GR, and total SOD, when compared to other studied
enzymes and MDA concentration, could have been
understood as a compensation mechanism, reducing the
potentially deleterious impact of ROS production on soleus
muscle metabolism and function under obesogenic condi-
tions. It can also reﬂect on the intrinsic diﬀerences between
the studied dietary patterns, in relation to the activity of anti-
oxidative/prooxidative systems.
The change of the diet from CD to HF or HF to CD
caused more disturbances in oxidative stress, measured by
enzymatic activity and MDA concentration, than remaining
on the same nutritional proﬁle. We suggest that the change
of a diet after 8 weeks, and hence the consumption of a diﬀer-
ent type of nutrients, inﬂuenced the biochemical pathways,
causing perturbations and irregularities in substrate catabo-
lism, which is also manifested in ROS production and antiox-
idative activity. Therefore, in relation to the general data
presented above, it can be hypothesised that the way DJOS
inﬂuences the soleus muscle’s antioxidative enzyme activity
is related to the type of diet implemented before and after
the surgery and the type of enzyme studied. Changing the
diet from CD to HF or vice versa seems to be the less prefer-
able method of treatment, and remaining on the stable diet,
preferably the control one, which is more favourable in terms
of antioxidative enzyme activity following bariatric surgery
would be the better option.
To our best knowledge, there has been no study per-
formed to date that examined MDA skeletal muscles’ activity
following a bariatric surgery procedure in relation neither to
HF or CD nor to animals or humans. Reduction of MDA
skeletal muscle’s activity following the bariatric surgery pro-
cedure stays in line with the recently performed study in
humans by Monzo-Beltran et al. However, the MDA activity
was measured in serum, not in skeletal muscle [45]. These
authors observed that MDA progressively decreased in
patients undergoing laparoscopic sleeve gastrectomy [45].
Even though bariatric surgery procedures have an advantage
in decreasing lipid peroxidation measured with MDA skele-
tal muscle’s concentration, the changes in the dietary pattern
(CD/HF; HF/CD) are less favourable in comparison with
HF/HF and CD/CD patterns. In the light of the presented
studies, it might be reﬂected that bariatric procedure has an
advantageous eﬀect in terms of mobilisation of antioxidative
systems and OS reduction. To our knowledge, the phenome-
non of diverse responses to OS ampliﬁed by HF diet across
diﬀerent muscle types has been studied [13]. Therefore, the
observations coming from soleus muscle are not necessarily
reﬂective of the redox response to diet and bariatric proce-
dures in all skeletal muscles. Thus, further studies are needed
to more widely explore our initial ﬁndings.
6. Conclusions
The dietary patterns applied for this research included com-
binations of the same diet before and after surgery (HF/HF,
CD/CD) as well as diﬀerent ones (HF/CD, CD/HF). After
16 weeks of the experiment and 8 weeks after DJOS and
SHAM surgery, we observed the following: (i) Enzymatic sys-
tems represented by GPX, CAT, CuZnSOD, and nonenzy-
matic MDA showed a signiﬁcantly lower level of activity
and concentration in muscle after DJOS surgery in compari-
son to SHAM-operated animals. (ii) GR showed a signiﬁ-
cantly increased activity after DJOS in relation to SHAM
operation. This may suggest a strong beneﬁcial impact of
DJOS surgery on the dynamics of antioxidative/oxidative
processes. (iii) A change in diet, regardless of the type of diet,
stimulated OS in DJOS-operated rats. (iv) For most of the
analysed parameters, we observed that the same type of diet
before and after surgery, which was HF/HF and CD/CD,
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induced OS less than a change in dietary pattern from HF to
CD or from CD to HF.
We conclude that metabolic surgery together with mixed
dietary patterns may be potentially used as a strategy to mod-
ulate oxidative stress under pathological conditions. Long-
term application of mixed control and obesogenic dietary
patterns led to signiﬁcant changes after DJOS surgery, many
times reducing its beneﬁcial eﬀect, measured by selected
antioxidants.
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